Immunostics HSGD-25 IFOBT Gold 25 Test Kit 25 Mailing

The Immunostics HSGD-25 IFOBT Gold 25 Test Kit is a comprehensive diagnostic solution designed for use in clinical settings, laboratories, and medical offices. This innovative kit offers a streamlined approach to testing, providing healthcare professionals with a reliable and efficient means of detecting occult blood in feces, a key indicator of gastrointestinal disorders. Its standout benefit lies in its user-friendly design and high sensitivity, making it an essential tool for medical professionals seeking to provide accurate diagnoses and effective patient care.

The Immunostics HSGD-25 IFOBT Gold 25 Test Kit is intended for the qualitative detection of human hemoglobin in feces, utilizing immunochromatographic assay technology. This test kit is designed to aid in the diagnosis of gastrointestinal bleeding and disorders, such as colorectal cancer, ulcers, and inflammatory bowel disease. The kit's components work in tandem to provide a rapid and accurate test result, facilitating prompt diagnosis and treatment.

Key Features

• Highly sensitive and specific immunochromatographic assay technology for accurate results
• Easy-to-use design, minimizing the risk of user error and ensuring reliable test outcomes
• Rapid test results, allowing for timely diagnosis and treatment
• Includes 25 mailing envelopes, sampler slide, 25 tubes, and cassettes for comprehensive testing
• Convenient packaging and compact design for efficient storage and transportation
• Simple, intuitive testing process, reducing training requirements for healthcare staff
• Supports early detection and monitoring of gastrointestinal disorders, enabling targeted interventions

Product Specifications

• Dimensions: Not specified • Weight: Not specified • Materials: Not specified • Compliance: Not specified • Compatibility: Designed for use in clinical settings, laboratories, and medical offices

Ideal For

• Hospitals and healthcare systems • Clinical laboratories and diagnostic centers • Medical offices and private practices • Research institutions and universities • Public health organizations and screening programs • Home care and remote testing services (with appropriate medical supervision)